Anne Elise Eggen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anne Elise Eggen has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Anders Engeland
Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
1 shared publication - Ingeborg Hartz
Faculty of Public Health, Hedmark University College, Elverum, Norway
1 shared publication - Inger Njølstad
Institute of Community Medicine, University of Tromsø, Norway
1 shared publication - Kari Furu
Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
1 shared publication - Solveig Sakshaug
Norwegian Institute of Public Health, Oslo, Norway
1 shared publication - Svetlana Skurtveit
Norwegian Centre for Addiction Research Institute of Clinical Medicine University of Oslo Oslo Norway
1 shared publication
Latest Publications
- Open Access
- 5 December 2007
- Published by Springer Nature in BMC Clinical Pharmacology
- Vol. 7 (1) , 14
Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption – an individual-level prescription database study
A previous study has shown that variations in threshold and intensity (lipid goal attainment) of statins for primary prevention contribute to regional differences in overall consumption of statins in Norway. Our objective was to explore how differences in prevalences of use, dosing characteristics, choice of statin and continuity of therapy in individual patients adds new information to previous results.
- 5 December 2007
- Published by Springer Nature in BMC Clinical Pharmacology
- Vol. 7 (1) , 14
Open AccessAspects of statin prescribing in Norwegian counties with high, average and low statin consumption – an individual-level prescription database study
A previous study has shown that variations in threshold and intensity (lipid goal attainment) of statins for primary prevention contribute to regional differences in overall consumption of statins in Norway. Our objective was to explore how differences in prevalences of use, dosing characteristics, choice of statin and continuity of therapy in individual patients adds new information to previous results.